Myomics Q— 510(k) K211432

Substantially Equivalent

Phantomics, Inc.

FDA 510(k) clearance K211432 for Myomics Q, Substantially Equivalent on 2021-11-23. Applicant: Phantomics, Inc..

Clearance details

Applicant: Phantomics, Inc.
Product code: Code LLZ
Advisory panel: Radiology
Date received: 2021-05-07
Decision date: 2021-11-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Seoul, KR

Download summary PDF View on FDA.gov ↗

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.